A mutational analysis of the transforming functions of the E8 protein of bovine papillomavirus type 4

Virology

Volumn 255, Issue 2, 1999, Pages 385-394

  O'Brien, Vincent ^a   Ashrafi, G Hossein ^a   Grindlay, G Joan ^a   Anderson, Ruth ^a   Campo, M Saveria ^a  

^a BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

BPV 4; Cell transformation; Cyclin A; E8

Indexed keywords

CYCLIN A; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CELL TRANSFORMATION; GENE EXPRESSION; GENE MUTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PAPILLOMA VIRUS; PHENOTYPE; PRIORITY JOURNAL; TRANSACTIVATION;

ANIMALIA; BOVINAE; BOVINE PAPILLOMAVIRUS; BOVINE PAPILLOMAVIRUS TYPE 1; BOVINE PAPILLOMAVIRUS TYPE 4; BOVINE PARVOVIRUS; DNA VIRUSES; PAPILLOMAVIRUS;

EID: 0033558736     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9563     Document Type: Article

References (20)

1. Anderson R. A., Scobie L., O'Neil B. W., Grindlay G. J., Campo M. S. Viral proteins of bovine papillomavirus type 4 during the development of alimentary canal tumours. Vet. J. 154:1997;69-78.
2. Banks L., Matlashewski G. Biochemical and biological activities of the HPV E5 proteins. Papillomavirus Reviews: Current Research on Papillomaviruses. 1996;Leeds University Press, Leeds. p. 39-45.
3. Cairney M., Campo M. S. The synergism between bovine papillomavirus type 4 and quercetin is dependent on the timing of exposure. Carcinogenesis. 16:1995;1997-2001.
4. Crook T., Ludwig R. L., Marston N. J., Willkomm D., Vousden K. H. Sensitivity of p53 lysine mutants to ubiquitin-directed degradation targeted by human papillomavirus E6. Virology. 217:1996;285-292.
5. Faccini A. M., Cairney M., Ashrafi G. H., Finbow M. E., Campo M. S., Pitts J. D. The bovine papillomavirus type 4 E8 protein binds to ductin and causes loss of gap junctional intercellular communication in primary fibroblasts. J. Virol. 70:1996;9041-9045.
6. +. J. Virol. 66:1992;405-413.
7. Green M., Loewenstein P. M. Demonstration that a chemically synthesised BPV-1 oncoprotein and its C-terminal domain function to induce cellular DNA synthesis. Cell. 51:1987;795-802.
8. Halbert C. L., Galloway D. A. Identification of the E5 open reading frame of human papillomavirus type 16. J. Virol. 62:1988;1071-1075.
9. Jackson M. E., O'Brien V., Morgan I. M., Grindlay G. J., Campo M. S. Bovine papillomavirus type 4: Neoplastic cell transformation and control of infection by vaccination. Int. J. Oncol. 9:1996;1189-1199.
10. Jackson M. E., Pennie W. D., McCaffery R. E., Smith K. T., Grindlay G. J., Campo M. S. The B subgroup bovine papillomaviruses lack an identifiable E6 open reading frame. Mol. Carcinogenesis. 4:1991;382-387.
11. Jaggar R. T., Pennie W. D., Smith K. T., Jackson M. E., Campo M. S. Co-operation between bovine papillomavirus type 4 and ras in the morphological transformation of primary bovine fibroblasts. J. Gen. Virol. 71:1990;3041-3046.
12. Jarrett W. F. H., O'Neil B. W., Gaukroger J. M., Smith K. T., Laird H. M., Campo M. S. Studies on vaccination against papillomaviruses - The immunity after infection and vaccination with bovine papillomaviruses of different types. Vet. Rec. 126:1990;473-475.
13. Kramer A., Carstens C. P., Fahl W. E. A novel CCAAT-binding protein necessary for adhesion-dependent cyclin-A transcription at the G1/S boundary is sequestered by a retinoblastoma-like protein in G0. J. Biol. Chem. 271:1996;6579-6582.
14. Kulke R., Horwitz B. H., Zibello T., DiMaio D. The central hydrophobic domain of the bovine papillomavirus E5 transforming protein can be functionally replaced by many hydrophobic amino acid sequences containing a glutamine. J. Virol. 66:1992;505-511.
15. KIP1. Oncogene. 17:1998;293-301.
16. Pennie W. D., Grindlay G. J., Cairney M., Campo M. S. Analysis of the transforming functions of bovine papillomavirus type 4. Virology. 193:1993;614-620.
17. Schiller J. T., Vass W. C., Vousden K. H., Lowy D. R. E5 open reading frame of bovine papillomavirus type 1 encodes a transforming gene. J. Virol. 57:1986;1-6.
18. Scobie L., Jackson M. E., Campo M. S. The role of exogenous p53 and E6 oncoproteins inin vitro. J. Gen. Virol. 78:1997;3001-3008.
19. Sparkowski J., Anders J., Schlegel R. Mutation of the bovine papillomavirus E5 oncoprotein at amino acid 17 generates both high- and low-transforming variants. J. Virol. 68:1994;6120-6123.
20. Sparkowski J., Mense M., Anders J., Schlegel R. E5 oncoprotein transmembrane mutants dissociate fibroblast transforming activity from 16-kilodalton protein binding and platelet-derived growth factor receptor binding and phosphorylation. J. Virol. 70:1996;2420-2430.